Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 121

1.

GATA4 protects granulosa cell tumors from TRAIL-induced apoptosis.

Kyrönlahti A, Kauppinen M, Lind E, Unkila-Kallio L, Butzow R, Klefström J, Wilson DB, Anttonen M, Heikinheimo M.

Endocr Relat Cancer. 2010 Jul 28;17(3):709-17. doi: 10.1677/ERC-10-0041. Print 2010 Sep.

2.

TRAIL pathway components and their putative role in granulosa cell apoptosis in the human ovary.

Jääskeläinen M, Kyrönlahti A, Anttonen M, Nishi Y, Yanase T, Secchiero P, Zauli G, Tapanainen JS, Heikinheimo M, Vaskivuo TE.

Differentiation. 2009 Apr;77(4):369-76. doi: 10.1016/j.diff.2008.12.001. Epub 2009 Jan 20.

PMID:
19281785
3.

Cisplatin-mediated sensitivity to TRAIL-induced cell death in human granulosa tumor cells.

Woods DC, Alvarez C, Johnson AL.

Gynecol Oncol. 2008 Mar;108(3):632-40. doi: 10.1016/j.ygyno.2007.11.034. Epub 2008 Jan 14.

PMID:
18191995
4.
5.

Tumor necrosis factor-related apoptosis-inducing ligand-mediated apoptosis in established and primary glioma cell lines.

Jaganathan J, Petit JH, Lazio BE, Singh SK, Chin LS.

Neurosurg Focus. 2002 Sep 15;13(3):ecp1.

PMID:
15844877
6.

FOXL2, GATA4, and SMAD3 co-operatively modulate gene expression, cell viability and apoptosis in ovarian granulosa cell tumor cells.

Anttonen M, Pihlajoki M, Andersson N, Georges A, L'hôte D, Vattulainen S, Färkkilä A, Unkila-Kallio L, Veitia RA, Heikinheimo M.

PLoS One. 2014 Jan 9;9(1):e85545. doi: 10.1371/journal.pone.0085545. eCollection 2014.

7.

Inhibition of proteasome activity sensitizes human granulosa tumor cells to TRAIL-induced cell death.

Woods DC, Liu HK, Nishi Y, Yanase T, Johnson AL.

Cancer Lett. 2008 Feb 18;260(1-2):20-7. Epub 2007 Nov 26.

PMID:
18031928
8.

Anti-Müllerian hormone inhibits growth of AMH type II receptor-positive human ovarian granulosa cell tumor cells by activating apoptosis.

Anttonen M, Färkkilä A, Tauriala H, Kauppinen M, Maclaughlin DT, Unkila-Kallio L, Bützow R, Heikinheimo M.

Lab Invest. 2011 Nov;91(11):1605-14. doi: 10.1038/labinvest.2011.116. Epub 2011 Aug 1.

9.

Targeting pro-apoptotic trail receptors sensitizes HeLa cervical cancer cells to irradiation-induced apoptosis.

Maduro JH, de Vries EG, Meersma GJ, Hougardy BM, van der Zee AG, de Jong S.

Int J Radiat Oncol Biol Phys. 2008 Oct 1;72(2):543-52. doi: 10.1016/j.ijrobp.2008.06.1902.

PMID:
18793956
10.

TRAIL resistance of breast cancer cells is associated with constitutive endocytosis of death receptors 4 and 5.

Zhang Y, Zhang B.

Mol Cancer Res. 2008 Dec;6(12):1861-71. doi: 10.1158/1541-7786.MCR-08-0313.

11.

Thapsigargin potentiates TRAIL-induced apoptosis in giant cell tumor of bone.

Huang L, Xu J, Li K, Zheng MH, Kumta SM.

Bone. 2004 Jun;34(6):971-81.

PMID:
15193543
12.
13.

Chemotherapy induces death receptor 5 in epithelial ovarian carcinoma.

Arts HJ, de Jong S, Hollema H, ten Hoor K, van der Zee AG, de Vries EG.

Gynecol Oncol. 2004 Mar;92(3):794-800.

PMID:
14984943
14.
15.

DR4-selective tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) variants obtained by structure-based design.

Tur V, van der Sloot AM, Reis CR, Szegezdi E, Cool RH, Samali A, Serrano L, Quax WJ.

J Biol Chem. 2008 Jul 18;283(29):20560-8. doi: 10.1074/jbc.M800457200. Epub 2008 May 12.

16.

Rosiglitazone promotes tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis by reactive oxygen species-mediated up-regulation of death receptor 5 and down-regulation of c-FLIP.

Kim YH, Jung EM, Lee TJ, Kim SH, Choi YH, Park JW, Park JW, Choi KS, Kwon TK.

Free Radic Biol Med. 2008 Mar 15;44(6):1055-68. doi: 10.1016/j.freeradbiomed.2007.12.001. Epub 2007 Dec 8.

PMID:
18164688
17.

Expression of TRAIL and TRAIL death receptors in stage III non-small cell lung cancer tumors.

Spierings DC, de Vries EG, Timens W, Groen HJ, Boezen HM, de Jong S.

Clin Cancer Res. 2003 Aug 15;9(9):3397-405.

18.
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk